LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical ...
The new application relates to how Akari’s novel PH1 payload demonstrates its ability to modulate the spliceosome to disrupt ...
The comprehensive report from the bipartisan National Security Commission on Emerging Biotechnology (NSCEB) delivers a “sobering, even frightening,” conclusion: that China is quickly ascending to ...
Do you want to be at the forefront of the rapidly growing biotechnology field? Do you want to develop products derived from living organisms and biomolecules? Do you have a passion for biochemistry, ...
The CEO's move is widely interpreted as a strong vote of confidence in the company's long-term strategy. Nautilus is pursuing a transformative goal in the proteomics sector with its single-molecule ...
There are more than 667,000 military veterans living in North Carolina, which is approximately 8.3 percent of the state's adult population. Many of these veterans are below retirement age, which means ...
SOUTH SAN FRANCISCO, Calif., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant ...
Pictured: Dolores Grijalva a student in MiraCosta College's Biomanufacturing Bachelor's Degree program, the first bachelor's degree of its kind at a community college. A university isn’t the only ...
About NKGen Biotech NKGen is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic NK cell therapeutics. NKGen is ...
To regain compliance with the Listing Rule, the Company’s shares were required to maintain a minimum closing bid price of $1.00 for at least 10 consecutive business days, which was achieved on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback